Estrella Immunopharma, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Cheng Liu, CEO and a Director of Estrella Immunopharma, Inc., reported multiple transactions in common stock on August 25, 2026.
NASDAQ
Jiandong Xu, Chief Financial Officer of Estrella Immunopharma, Inc., reported multiple transactions in common stock on August 18, 2026.
NASDAQ
Estrella Immunopharma's Chief Financial Officer Jiandong Xu acquired 2,100 shares of common stock through multiple open market purchases.
NASDAQ
Estrella Immunopharma's CEO, Cheng Liu, received incentive and nonstatutory share options totaling 1,000,000 shares on October 30, 2024.
NASDAQ
Estrella Immunopharma's CFO, Jiandong Xu, received incentive and nonstatutory share options totaling 1,000,000 shares on October 30 and 31, 2024, respectively, with vesting schedules.